AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PROTEOMICS INTERNATIONAL LAB

0.535

+0.0254.90%

Volume:136.47K

Turnover:72.79K

Market Cap:87.60M

PE:-8.85

High:0.540

Open:0.520

Low:0.520

Close:0.510

52wk High:0.840

52wk Low:0.285

Shares:163.73M

Float Shares:121.55M

Volume Ratio:0.34

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.060

EPS(LYR):-0.060

ROE:-73.41%

ROA:-40.28%

PB:6.65

PE(LYR):-8.85

Loading ...

Overview Company News Filings

BRIEF-Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic Test

BUZZ-Proteomics at 9-month high on securing US patent for diagnostic test

Proteomics International Laboratories - US Patent Secured for Promarkereso Diagnostic Test for Esophageal Adenocarcinoma

THOMSON REUTERS

Proteomics International Laboratories Ltd-Promarkerd Changes How Doctors Manage Dkd - Study Published

THOMSON REUTERS

Proteomics Says Blood Test Shows 'Promising' Prognostic Accuracy for Diabetic Kidney Disease in Aboriginals

MT Newswires Live

We're Not Very Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn Rate

Simply Wall St.

Proteomics Says US CMS Sets Reimbursement Price for Kidney Disease Predictive Test; Shares Rise 16%

MT Newswires Live

Proteomics Says Racehorse Performance Data Confirms Potential of Unit's Stress Testing Technology; Shares Jump 5%

MT Newswires Live

BRIEF-Proteomics International Laboratories Receives A$2.2M In Research And Development Tax Incentive

Proteomics International Laboratories - All Figures in AUD

THOMSON REUTERS

Proteomics International Laboratories Ltd-Proteomics International Receives $2.2M in R&D Tax Incentive

THOMSON REUTERS

Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test

MT Newswires Live

Proteomics International Laboratories Ltd - All Figures in AUD

THOMSON REUTERS

Proteomics International Laboratories Ltd-Quarterly Activities/Appendix 4C Cash Flow Report

THOMSON REUTERS

Proteomics International Laboratories Secures Expansion of Collaboration with Victoria University, Hospital; Shares Up 3%

MT Newswires Live

Proteomics International Laboratories Ltd-Appointment of Director

THOMSON REUTERS

Proteomics International Says Blood Test Shows Diagnostic Accuracy for All Stages of Esophageal Cancer, Shares Rise 7%

MT Newswires Live

Proteomics International Secures ISO 15189 Certification For Australian Diagnostic Lab Operations, Shares Up 3%

MT Newswires Live

BRIEF-Proteomics International Laboratories Says Richard Lipscombe To Retire As Managing Director

Proteomics International Laboratories - Richard Lipscombe to Retire as Managing Director

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PIQ.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PIQ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","market":"AU","secType":"STK","nameCN":"PROTEOMICS INTERNATIONAL LAB","latestPrice":0.535,"timestamp":1766380320000,"preClose":0.51,"halted":0,"volume":136472,"delay":0,"nameEN":"PROTEOMICS INTERNATIONAL LAB","floatShares":121549097,"shares":163731857,"eps":-0.060439,"marketStatus":"Not Yet Opened","change":0.025,"latestTime":"12-22 16:12:00 AEDT","open":0.52,"high":0.54,"low":0.52,"amount":72792,"amplitude":0.039216,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.060439,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766444400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.51,"openAndCloseTimeList":[[1766358000000,1766379600000]],"volumeRatio":0.34036788230090365,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","floatShares":121549097,"roa":"-40.28%","roe":"-73.41%","lyrEps":-0.060439,"volumeRatio":0.34036788230090365,"shares":163731857,"dividePrice":0,"high":0.54,"amplitude":0.039216,"preClose":0.51,"low":0.52,"week52Low":0.285,"pbRate":"6.65","psRate":"26.44","week52High":0.84,"institutionHeld":0,"latestPrice":0.535,"eps":-0.060439,"divideRate":0,"volume":136472,"delay":0,"ttmEps":-0.060439,"open":0.52,"prevYearClose":0.8,"prevWeekClose":0.51,"prevMonthClose":0.405,"prevQuarterClose":0.35,"fiveDayClose":0.48,"twentyDayClose":0.335,"sixtyDayClose":0.365},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PIQ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PIQ.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PIQ.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592951467","title":"BRIEF-Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2592951467","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592951467?lang=en_us&edition=fundamental","pubTime":"2025-12-17 09:17","pubTimestamp":1765934265,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic TestDec 17 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX:US PATENT SECURED FOR PROMARKERES","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XM0LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2592563099","title":"BUZZ-Proteomics at 9-month high on securing US patent for diagnostic test","url":"https://stock-news.laohu8.com/highlight/detail?id=2592563099","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592563099?lang=en_us&edition=fundamental","pubTime":"2025-12-17 08:13","pubTimestamp":1765930380,"startTime":"0","endTime":"0","summary":"BUZZ-Proteomics at 9-month high on securing US patent for diagnostic test** Shares of Australia's Proteomics International Laboratories PIQ.AX rise as much as 7.6% to A$0.570, their highest level since late-February** Medical technology firm secures U.S. patent for PromarkerEso diagnostic testfor early diagnosis of esophageal cancer** Stock is down 28.8% YTD,  including the session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL6N3XN00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2592504930","title":"Proteomics International Laboratories - US Patent Secured for Promarkereso Diagnostic Test for Esophageal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2592504930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592504930?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:33","pubTimestamp":1765920838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XM0LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2591462237","title":"Proteomics International Laboratories Ltd-Promarkerd Changes How Doctors Manage Dkd - Study Published","url":"https://stock-news.laohu8.com/highlight/detail?id=2591462237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591462237?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:46","pubTimestamp":1765835161,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUE8GR1JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2591694515","title":"Proteomics Says Blood Test Shows 'Promising' Prognostic Accuracy for Diabetic Kidney Disease in Aboriginals","url":"https://stock-news.laohu8.com/highlight/detail?id=2591694515","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591694515?lang=en_us&edition=fundamental","pubTime":"2025-12-15 11:50","pubTimestamp":1765770622,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said its PromarkerD predictive blood test has the potential to support earlier, more accurate identification of kidney disease risk in Aboriginal Australians with type 2 diabetes, according to a Monday filing with the Australian bourse.The test delivered a 'rule out' rate of over 85% in Aboriginal participants, showing that a low score can reliably identify individuals unlikely to experience near-term kidney function decline.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2586299927","title":"We're Not Very Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299927","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299927?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:52","pubTimestamp":1764201165,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/were-not-very-worried-about-proteomics-international-laborat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/were-not-very-worried-about-proteomics-international-laborat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2586528032","title":"Proteomics Says US CMS Sets Reimbursement Price for Kidney Disease Predictive Test; Shares Rise 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586528032","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586528032?lang=en_us&edition=fundamental","pubTime":"2025-11-26 13:00","pubTimestamp":1764133200,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said the US Centers for Medicare & Medicaid Services set a reimbursement price of $390.75 for Promarker D, the company's predictive test for diabetic kidney disease, effective Jan.1, 2026, according to a Wednesday filing with the Australian bourse.The company will now seek to obtain private health insurer coverage, the filing said.Shares of the company rose 16% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","LU1894683264.USD","BK4585","BK4588","BK7508","LU0553294199.USD","LU0949170772.SGD","LU2637428348.USD","CMS","LU0545039389.USD","LU1003077747.HKD","LU1894683348.USD","LU2500361329.USD","LU0661504455.SGD","LU2346227817.USD","BK7048","BK4208","LU0738911758.USD"],"gpt_icon":0},{"id":"2585437143","title":"Proteomics Says Racehorse Performance Data Confirms Potential of Unit's Stress Testing Technology; Shares Jump 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585437143","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585437143?lang=en_us&edition=fundamental","pubTime":"2025-11-24 11:47","pubTimestamp":1763956054,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said performance data on Australian thoroughbred racehorses supports the potential of its OxiDx unit's oxidative stress testing technology in providing insight into the physiological readiness of racehorses, according to a Monday filing with the Australian bourse.New findings gathered using the OxiDx test showed that thoroughbred horses racing without oxidative stress were 76% more likely to place and 49% more likely to win than horses with oxidative stress, the filing said.Horses racing without oxidative stress increased the likelihood of winning or placing in the top three, the filing added.Shares of the company rose 5% in recent Monday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","PIQ.AU","XJO.AU","XAO.AU","XKO.AU","BK7048"],"gpt_icon":0},{"id":"2582314475","title":"BRIEF-Proteomics International Laboratories Receives A$2.2M In Research And Development Tax Incentive","url":"https://stock-news.laohu8.com/highlight/detail?id=2582314475","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582314475?lang=en_us&edition=fundamental","pubTime":"2025-11-12 09:21","pubTimestamp":1762910506,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Receives A$2.2M In Research And Development Tax IncentiveNov 12  - Proteomics International Laboratories Ltd PIQ.AX:PROTEOMICS INTERNATIONAL RECEIVES A$2.2M IN RESEARCH AND DEVELOPMENT TAX INCENTIVEFurther company coverage: PIQ.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUE5YB9L6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2582318575","title":"Proteomics International Laboratories -  All Figures in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2582318575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582318575?lang=en_us&edition=fundamental","pubTime":"2025-11-12 06:04","pubTimestamp":1762898668,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUE5YB9L6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2582185273","title":"Proteomics International Laboratories Ltd-Proteomics International Receives $2.2M in R&D Tax Incentive","url":"https://stock-news.laohu8.com/highlight/detail?id=2582185273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582185273?lang=en_us&edition=fundamental","pubTime":"2025-11-12 06:04","pubTimestamp":1762898668,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUE5YB9L6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2581003705","title":"Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2581003705","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581003705?lang=en_us&edition=fundamental","pubTime":"2025-11-06 14:29","pubTimestamp":1762410577,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  received a AU$500,000 grant from the Western Australian government to accelerate the commercialization of its blood test for the early diagnosis of endometriosis, according to a Thursday Australian bourse filing.The funding was provided by the Western Australian government's Future Health Research and Innovation Fund. It will contribute to commercialization activities, including regulatory engagement, marketing, and partnership development.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","BK7048","BK4168","XJO.AU","WRN","BK7508","XAO.AU","XKO.AU"],"gpt_icon":0},{"id":"2581033533","title":"Proteomics International Laboratories Ltd - All Figures in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2581033533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581033533?lang=en_us&edition=fundamental","pubTime":"2025-11-06 10:52","pubTimestamp":1762397523,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUE2HYPVB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2578663981","title":"Proteomics International Laboratories Ltd-Quarterly Activities/Appendix 4C Cash Flow Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2578663981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578663981?lang=en_us&edition=fundamental","pubTime":"2025-10-27 06:50","pubTimestamp":1761519051,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251026:nTUE3CX0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2575224221","title":"Proteomics International Laboratories Secures Expansion of Collaboration with Victoria University, Hospital; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575224221","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575224221?lang=en_us&edition=fundamental","pubTime":"2025-10-15 08:57","pubTimestamp":1760489844,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  secured an expansion of its research collaboration with the University of Melbourne and the Royal Women's Hospital in Victoria, according to a Wednesday filing with the Australian bourse.The collaboration aims to validate the company's PromarkerEndo blood test for endometriosis diagnosis and identify tissue-specific biomarkers for future specialized diagnostic tests, the filing said.PromarkerEndo is expected to be launched in Australia in the second half of the year, according to the filing.Shares rose nearly 3% in morning trade on Wednesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","BK7508","VCCTF","BK7048","XJO.AU","XAO.AU","BK4095","XKO.AU"],"gpt_icon":0},{"id":"2575235459","title":"Proteomics International Laboratories Ltd-Appointment of Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2575235459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575235459?lang=en_us&edition=fundamental","pubTime":"2025-10-14 06:02","pubTimestamp":1760392964,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nTUE65FY31:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2568233388","title":"Proteomics International Says Blood Test Shows Diagnostic Accuracy for All Stages of Esophageal Cancer, Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568233388","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568233388?lang=en_us&edition=fundamental","pubTime":"2025-09-19 10:14","pubTimestamp":1758248054,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said results from a 350-person study for its blood test for esophageal adenocarcinoma, PromarkerEso, showed that the test has excellent discrimination for all stages of the cancer, as well as high levels of sensitivity, specificity, positive and negative predictive values for all stages, according to a Friday Australian bourse filing.The results of the study demonstrated that the increasing severity of disease is significantly correlated with increasing PromarkerEso test scores.The test also showed acceptable performance for diagnosing the pre-malignant condition Barrett's Esophagus with high-grade dysplasia.The results of the study will be presented at the ISDE World Congress for Esophageal Diseases in Brisbane on Friday, and PromarkerEso will be formally launched at the conference. The test is available across Australia to patients through a telehealth consultation and physician referral.Its shares rose 7% in recent trading on Friday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7048","PIQ.AU","XKO.AU","BK7508","XJO.AU"],"gpt_icon":0},{"id":"2568446872","title":"Proteomics International Secures ISO 15189 Certification For Australian Diagnostic Lab Operations, Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568446872","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568446872?lang=en_us&edition=fundamental","pubTime":"2025-09-18 08:31","pubTimestamp":1758155460,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  has been granted ISO 15189 certification for its Australian laboratory operations, a milestone in the commercialization and clinical use of its precision diagnostic tests, according to a Thursday Australian bourse filing.The ISO 15189 certification is the global standard specifically for medical laboratories, outlining the quality management and technical requirements necessary to ensure accurate and dependable test results, the filing added.The company's shares rose past 3% in recent Thursday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7048","XAO.AU","ISO","PIQ.AU","XKO.AU","XJO.AU","BK4121"],"gpt_icon":0},{"id":"2566651309","title":"BRIEF-Proteomics International Laboratories Says Richard Lipscombe To Retire As Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2566651309","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566651309?lang=en_us&edition=fundamental","pubTime":"2025-09-09 09:22","pubTimestamp":1757380937,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Says Richard Lipscombe To Retire As Managing DirectorSept 9 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX:RICHARD LIPSCOMBE TO RETIRE AS MANAGING DIRECTORFurther company coverage: PIQ.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UV1CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2566658161","title":"Proteomics International Laboratories - Richard Lipscombe to Retire as Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2566658161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566658161?lang=en_us&edition=fundamental","pubTime":"2025-09-09 06:54","pubTimestamp":1757372045,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nFWN3UV1CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}]}}